BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8696774)

  • 1. Interaction of 2,4,4'-trichloro-2'-hydroxydiphenyl ether with microsomal cytochrome P450-dependent monooxygenases in rat liver.
    Hanioka N; Omae E; Nishimura T; Jinno H; Onodera S; Yoda R; Ando M
    Chemosphere; 1996 Jul; 33(2):265-76. PubMed ID: 8696774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of 2,4,4'-trichloro-2'-hydroxydiphenyl ether on cytochrome P450 enzymes in the rat liver.
    Hanioka N; Jinno H; Nishimura T; Ando M
    Chemosphere; 1997 Feb; 34(4):719-30. PubMed ID: 9569940
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in cytochrome P450 enzymes by 1,1-dichloroethylene in rat liver and kidney.
    Hanioka N; Jinno H; Nishimura T; Ando M
    Arch Toxicol; 1997; 72(1):9-16. PubMed ID: 9458185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of curcumin on cytochrome P450 and glutathione S-transferase activities in rat liver.
    Oetari S; Sudibyo M; Commandeur JN; Samhoedi R; Vermeulen NP
    Biochem Pharmacol; 1996 Jan; 51(1):39-45. PubMed ID: 8534266
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The inhibition of CYP enzymes in mouse and human liver by pilocarpine.
    Kimonen T; Juvonen RO; Alhava E; Pasanen M
    Br J Pharmacol; 1995 Feb; 114(4):832-6. PubMed ID: 7773543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of tetrachloroethylene with rat hepatic microsomal P450-dependent monooxygenases.
    Hanioka N; Jinno H; Takahashi A; Nakano K; Yoda R; Nishimura T; Ando M
    Xenobiotica; 1995 Feb; 25(2):151-65. PubMed ID: 7618343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of alachlor on hepatic cytochrome P450 enzymes in rats.
    Hanioka N; Watanabe K; Yoda R; Ando M
    Drug Chem Toxicol; 2002 Feb; 25(1):25-37. PubMed ID: 11850968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytochrome P450 (P450) isoenzyme specific dealkylation of alkoxyresorufins in rat brain microsomes.
    Dhawan A; Parmar D; Dayal M; Seth PK
    Mol Cell Biochem; 1999 Oct; 200(1-2):169-76. PubMed ID: 10569197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of rat hepatic cytochrome P450 activities by biodegradation products of 4-tert-octylphenol ethoxylate.
    Hanioka N; Jinno H; Chung ; Tanaka-Kagawa T; Nishimura T; Ando M
    Xenobiotica; 1999 Sep; 29(9):873-83. PubMed ID: 10548448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of rociverine on P450-dependent monooxygenases and its N-deethylation metabolism in rat liver microsomes.
    Menicagli S; Lippi A; Criscuoli M; Gervasi PG
    Biochem Pharmacol; 1993 Mar; 45(5):1097-105. PubMed ID: 8461039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of bioflavonoids on hepatic P450 activities.
    Obermeier MT; White RE; Yang CS
    Xenobiotica; 1995 Jun; 25(6):575-84. PubMed ID: 7483658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytochrome P450 specificities of alkoxyresorufin O-dealkylation in human and rat liver.
    Burke MD; Thompson S; Weaver RJ; Wolf CR; Mayer RT
    Biochem Pharmacol; 1994 Aug; 48(5):923-36. PubMed ID: 8093105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. P450 enzyme CYP2B catalyzes the detoxification of diisopropyl fluorophosphate.
    Laaksonen M; Kaliste-Korhonen E; Kärenlampi S; Hänninen O
    Chem Biol Interact; 1995 Mar; 94(3):197-213. PubMed ID: 7820884
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effects of H2-receptor antagonists on cytochrome P450 in male ICR mice.
    Kim DH; Kim EJ; Han SS; Roh JK; Jeong TC; Park JH
    Hum Exp Toxicol; 1995 Aug; 14(8):623-9. PubMed ID: 7576828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoclonal antibody-directed characterization of benzene, ethoxyresorufin and pentoxyresorufin metabolism in rat liver microsomes.
    Nakajima T; Elovaara E; Park SS; Gelboin HV; Hietanen E; Vainio H
    Biochem Pharmacol; 1990 Sep; 40(6):1255-61. PubMed ID: 2403379
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9).
    Wen X; Wang JS; Kivistö KT; Neuvonen PJ; Backman JT
    Br J Clin Pharmacol; 2001 Nov; 52(5):547-53. PubMed ID: 11736863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute toxicity, percutaneous absorption and effects on hepatic mixed function oxidase activities of 2,4,4'-trichloro-2'-hydroxydiphenyl ether (Irgasan DP300) and its chlorinated derivatives.
    Kanetoshi A; Katsura E; Ogawa H; Ohyama T; Kaneshima H; Miura T
    Arch Environ Contam Toxicol; 1992 Jul; 23(1):91-8. PubMed ID: 1637203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of P-450 isoenzyme activities in Syrian golden hamster liver compared to rat liver as probed by the rate of 7-alkoxyresorufin-O-dealkylation.
    Blaich G; Göttlicher M; Cikryt P; Metzler M
    Chem Biol Interact; 1988; 67(1-2):129-38. PubMed ID: 3262434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in rat liver cytochrome P450 enzymes by atrazine and simazine treatment.
    Hanioka N; Jinno H; Tanaka-Kagawa T; Nishimura T; Ando M
    Xenobiotica; 1998 Jul; 28(7):683-98. PubMed ID: 9711812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro inhibition of liver monooxygenases by beta-ionone, 1,8-cineole, (-)-menthol and terpineol.
    De-Oliveira AC; Fidalgo-Neto AA; Paumgartten FJ
    Toxicology; 1999 Jul; 135(1):33-41. PubMed ID: 10454222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.